Skip to main content
Fig. 2  | Alzheimer's Research & Therapy

Fig. 2 

From: Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

Fig. 2 

ROC curve analysis for full-length neurogranin (FL-Ng) (green), C-terminal half of Ng (CT-Ng) (orange), and the ratio of CT-Ng/FL-Ng (turquoise) in the cerebrospinal fluid (CSF) for differentiation of mild cognitive impairment due to Alzheimer’s disease (MCI-AD) from controls (a) and Alzheimer’s disease (AD) patients from controls (b). The area under the curve (95% confidence interval) is shown in the incorporated table (c)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193